PMID: 9544956Apr 17, 1998Paper

Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center

Journal of the American College of Surgeons
B J O'HeaH S Cody

Abstract

Sentinel node biopsy (SNB) has emerged as a potential alternative to routine axillary dissection in clinically node-negative breast cancer. From September 1995 to June 1996 at Memorial Sloan-Kettering Cancer Center, 60 patients with clinically node-negative cancer underwent SNB, which was immediately followed by standard axillary dissection. Both blue dye and radioisotope were used to identify the sentinel node. SNB was compared with standard axillary dissection for its ability to accurately reflect the final pathologic status of the axillary nodes. The sentinel node was successfully identified by lymphoscintigraphy in 75% (42 of 56), by blue dye in 75% (44 of 59), by isotope in 88% (52 of 59), and by the combination of blue dye and isotope in 93% (55 of 59) of all 59 evaluable patients. Of the 55 patients in this study where sentinel nodes were identified, 20 (36%) were histologically positive. The sentinel node was falsely negative in three patients, yielding an accuracy of 95%. SNB was more accurate for T1 (98%) than for T2-T3 tumors (82%). Lymphatic mapping is technically feasible, reliably identifies a sentinel node in most cases, and appears more accurate for T1 tumors than for larger lesions. Blue dye and radioisotope ar...Continue Reading

Citations

Jan 7, 2005·The British Journal of Surgery·H CharfareA D Purushotham
Mar 29, 2002·Journal of Surgical Oncology·David M EuhusJames Huth
Dec 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiT Taniya
Oct 9, 2008·Breast Cancer : the Journal of the Japanese Breast Cancer Society·H S Cody
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·P I HaighA E Giuliano
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M MiyauchiM Matsumoto
Oct 13, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·S P LeongJ H Wong
Oct 13, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiK Tsugawa
Oct 13, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·E E Zervos, W E Burak
May 23, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M Noguchi
May 23, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Stephen P PovoskiBarbara S Ducatman
Dec 3, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kelly K Hunt, Merrick I Ross
Dec 3, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Nobuyuki TsunodaShigeto Miura
Dec 3, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masakuni Noguchi
Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kazuhiko SatoHidetaka Mochizuki
Dec 3, 1999·Annals of Nuclear Medicine·S ImotoN Moriyama
Mar 29, 2002·Irish Journal of Medical Science·R ManeckshaN J O'Higgins
Mar 29, 2002·Irish Journal of Medical Science·N NugentN O'Higgins
Sep 26, 2002·World Journal of Surgery·Jyh-Cherng YuTsu-Yi Chao
Feb 4, 2006·Current Treatment Options in Oncology·Farin Amersi, Nora M Hansen
Mar 19, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J L FougoM Dinis-Ribeiro
Jan 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R D MacmillanA J Evans
Nov 20, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M LeideniusK von Smitten
Feb 1, 2003·American Journal of Surgery·Boon ChuaConrad H Rusnak
Mar 7, 2003·American Journal of Surgery·Elias E SanidasDimitris D Tsiftsis
Oct 8, 1999·Disease-a-month : DM·K FordB Lum
Jan 5, 2001·The Surgical Clinics of North America·P A Treseler, P S Tauchi
Jan 5, 2001·The Surgical Clinics of North America·J H Wong
Jan 1, 1999·Journal of Nurse-midwifery·W F McCoolH M Bradford
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·G M FreedmanJ P Hoffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
R M RoumenL M Geuskens
© 2022 Meta ULC. All rights reserved